Physician profile
M Dennis
NPI 1447259809
$235,991.24
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172K · 2020: $133 · 2021: $64K.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $171,716.55 | 2019 | |
| Medtronic, INC. | $63,807.25 | 2021 | |
| Si-Bone, INC. | $229.71 | 2019-2021 | |
| Bioventus LLC | $86.35 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $48.42 | 2020-2021 | |
| Providence Medical Technology, INC. | $41.45 | 2020 | |
| Choice Spine, LLC | $35.64 | 2019-2021 | |
| Djo, LLC | $25.87 | 2021 |
1 company reported research payments only; those appear in the research section below.
Research and ownership
$169,624.25 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw M Dennis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.